Integrated BioPharma, Inc. (INBP)
OTCMKTS
· Delayed Price · Currency is USD
0.272
-0.028 (-9.30%)
Mar 6, 2026, 4:00 PM EST
Integrated BioPharma Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 5.31 | 3.62 | 1.68 | 1.32 | 0.33 | 0.21 | Upgrade
|
| Short-Term Investments | - | - | - | - | 0.01 | 0.07 | Upgrade
|
| Cash & Short-Term Investments | 5.31 | 3.62 | 1.68 | 1.32 | 0.34 | 0.28 | Upgrade
|
| Cash Growth | 115.93% | 115.56% | 27.43% | 283.67% | 23.83% | -48.32% | Upgrade
|
| Receivables | 3.59 | 5.43 | 4.67 | 4.51 | 4.89 | 5.78 | Upgrade
|
| Inventory | 8.36 | 9.36 | 11.24 | 10.26 | 11.06 | 11.7 | Upgrade
|
| Other Current Assets | 0.55 | 0.36 | 0.29 | 0.28 | 0.34 | 0.25 | Upgrade
|
| Total Current Assets | 17.82 | 18.76 | 17.88 | 16.37 | 16.63 | 18 | Upgrade
|
| Property, Plant & Equipment | 2.29 | 2.75 | 3.68 | 4.28 | 3.78 | 4.11 | Upgrade
|
| Long-Term Deferred Tax Assets | 3.39 | 3.34 | 4.6 | 4.73 | 4.8 | 3.27 | Upgrade
|
| Other Long-Term Assets | 0.05 | 0.05 | 0.06 | 0.06 | 0.05 | 0.07 | Upgrade
|
| Total Assets | 23.55 | 24.9 | 26.21 | 25.43 | 25.25 | 25.44 | Upgrade
|
| Accounts Payable | 2.14 | 2.27 | 2.51 | 2.27 | 3.21 | 3.5 | Upgrade
|
| Accrued Expenses | 1.13 | 1.3 | 2.66 | 1.63 | 1.41 | 1.61 | Upgrade
|
| Short-Term Debt | - | - | - | - | 0.1 | 2.17 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | 0.03 | 1.46 | Upgrade
|
| Current Portion of Leases | 0.27 | 0.68 | 0.95 | 0.93 | 0.51 | 0.5 | Upgrade
|
| Total Current Liabilities | 3.54 | 4.25 | 6.12 | 4.83 | 5.26 | 9.24 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.05 | - | Upgrade
|
| Long-Term Leases | 0.24 | 0.34 | 0.85 | 1.74 | 1.36 | 1.87 | Upgrade
|
| Total Liabilities | 3.78 | 4.58 | 6.97 | 6.57 | 6.68 | 11.11 | Upgrade
|
| Common Stock | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | Upgrade
|
| Additional Paid-In Capital | 51.86 | 51.77 | 51.5 | 51.24 | 50.92 | 50.52 | Upgrade
|
| Retained Earnings | -32.06 | -31.42 | -32.23 | -32.34 | -32.31 | -36.14 | Upgrade
|
| Treasury Stock | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | Upgrade
|
| Shareholders' Equity | 19.77 | 20.32 | 19.24 | 18.86 | 18.58 | 14.33 | Upgrade
|
| Total Liabilities & Equity | 23.55 | 24.9 | 26.21 | 25.43 | 25.25 | 25.44 | Upgrade
|
| Total Debt | 0.5 | 1.02 | 1.8 | 2.67 | 2.06 | 6 | Upgrade
|
| Net Cash (Debt) | 4.81 | 2.6 | -0.12 | -1.36 | -1.71 | -5.72 | Upgrade
|
| Net Cash Per Share | 0.16 | 0.08 | -0.00 | -0.05 | -0.05 | -0.18 | Upgrade
|
| Filing Date Shares Outstanding | 31.06 | 31.06 | 30.1 | 29.95 | 29.95 | 29.82 | Upgrade
|
| Total Common Shares Outstanding | 31.06 | 31.06 | 30.1 | 29.95 | 29.95 | 29.8 | Upgrade
|
| Working Capital | 14.28 | 14.52 | 11.75 | 11.54 | 11.36 | 8.76 | Upgrade
|
| Book Value Per Share | 0.64 | 0.65 | 0.64 | 0.63 | 0.62 | 0.48 | Upgrade
|
| Tangible Book Value | 19.77 | 20.32 | 19.24 | 18.86 | 18.58 | 14.33 | Upgrade
|
| Tangible Book Value Per Share | 0.64 | 0.65 | 0.64 | 0.63 | 0.62 | 0.48 | Upgrade
|
| Land | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | 1.25 | Upgrade
|
| Machinery | 7.44 | 7.25 | 7.11 | 6.8 | 6.73 | 6.42 | Upgrade
|
| Leasehold Improvements | 1.42 | 1.41 | 1.34 | 1.37 | 1.37 | 1.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.